Speaker Bio
Dr. Dhaval Shah is an Associate Professor at the University at Buffalo. He received his Ph.D. from the Department of Pharmaceutical Sciences at the University at Buffalo; and he was Principal Scientist at Pfizer Inc. before becoming a professor. His research focuses on understanding the determinants for the absorption, distribution, metabolism, and elimination (ADME) of protein therapeutics and novel biologics. His lab uses the principles of Pharmacokinetics-Pharmacodynamics (PK-PD) Modeling & Simulation to support the discovery, clinical translation, and late phase development of novel biologics like engineered antibodies, multi-specific proteins, immuno-oncology agents, engineered T cells, antibody-drug conjugates, and gene delivery vectors.
